Page last updated: 2024-08-24

nelfinavir and asparagine

nelfinavir has been researched along with asparagine in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blum, LE; Clemente, JC; Dunn, BM; Goodenow, MM; Hemrajani, R1
Bihani, SC; Das, A; Ferrer, JL; Hosur, MV; Prashar, V1
Berti, F; Bonini, C; Chiummiento, L; De Bonis, M; Di Blasio, N; Funicello, M; Lupattelli, P; Pandolfo, R; Tramutola, F1

Other Studies

3 other study(ies) available for nelfinavir and asparagine

ArticleYear
Secondary mutations M36I and A71V in the human immunodeficiency virus type 1 protease can provide an advantage for the emergence of the primary mutation D30N.
    Biochemistry, 2003, Dec-30, Volume: 42, Issue:51

    Topics: Alanine; Anti-HIV Agents; Asparagine; Aspartic Acid; Binding Sites; Drug Resistance, Viral; HIV Protease; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Isoleucine; Kinetics; Methionine; Mutagenesis, Site-Directed; Nelfinavir; Ritonavir; Valine

2003
Resistance mechanism revealed by crystal structures of unliganded nelfinavir-resistant HIV-1 protease non-active site mutants N88D and N88S.
    Biochemical and biophysical research communications, 2009, Nov-13, Volume: 389, Issue:2

    Topics: Asparagine; Aspartic Acid; Carbamates; Catalytic Domain; Crystallography, X-Ray; Drug Resistance, Viral; Furans; HIV Protease; HIV Protease Inhibitors; Humans; Hydrogen Bonding; Mutation; Nelfinavir; Sulfonamides

2009
Synthesis of new thienyl ring containing HIV-1 protease inhibitors: promising preliminary pharmacological evaluation against recombinant HIV-1 proteases.
    Journal of medicinal chemistry, 2010, Feb-25, Volume: 53, Issue:4

    Topics: Asparagine; HIV Protease; HIV Protease Inhibitors; Mutation; Nelfinavir; Quinolines; Recombinant Proteins; Saquinavir; Stereoisomerism; Structure-Activity Relationship

2010